2025 Partners
Expertise Partners
myTomorrows
myTomorrows is a global health tech company dedicated to helping patients and physicians discover and access treatment options. We’ve partnered with 50+ BioPharma companies to support global expanded access programs, gather invaluable real-world data, and streamline patient recruitment for clinical trials. We are experts in the field of expanded access, having gained experience over a decade, and we manage all aspects of expanded access - from regulatory strategy program setup to full operational execution. We distinguish ourselves by taking a proactive stakeholder-focused approach.
Early Access Care
Early Access Care is a full-scale specialist service provider of Compassionate Use and Named Patient Programs, ranging from programme planning, protocol development, end-to-end operational management, Real World Data services, and a variety of customized service offerings. We work with biotech and pharmaceutical companies to set up and manage programs in the pre and post-approval space, including post-trial access, managing all regulatory and logistical aspects of early access. Speak with one of our representatives at the EAC booth to find out more about how our service and staff may support your plans.
Program Partners
WEP
At WEP, we are With Every Patient, as we believe every patient should have access to treatment! We operate as a Pharma Services Provider (PSP) that is committed to providing Drug Development and Treatment Access Solutions for patients worldwide. We specialize in Expanded Access Programs (EAPs) and help Sponsors deliver value-driven EAPs that are designed and fit around their specific needs and development pipeline. Our programs are delivered through High Quality, High Service, and High Value, returning a positive ROI to all Sponsors we have partnered with.
Inceptua
Inceptua Group (Inceptua) is a provider of customized access solutions that enable pharmaceutical companies to overcome challenges and eliminate obstacles to reach patients with unmet medical needs and provide access to life-changing or life-extending therapies. The group was founded in 1997, initially focused on sourcing comparator products and delivering services for clinical trials. Later Inceptua was expanded in 2017 with the establishment of Inceptua Early Access, running early access programs worldwide. Inceptua’s Early Access team combine regulatory and operational expertise with an ability to partner effectively with clients to confidently provide the guidance, recommendations and capabilities necessary to successfully plan for and execute global access programs. Collectively, our experience covers 300+ early access programs, involving both free-of-charge and charged for products treating a variety of conditions, including many rare and orphan indications. Our team leverage a wealth of expertise in managing the distribution of medicines to more than 120 countries around the world, including North America, the EU, LATAM, MENA, APAC regions and low/middle income countries across the globe.
Uniphar
Uniphar is a trusted global partner to pharma, medtech and biotech companies, working to improve patient access to medicines around the world. Uniphar’s team of experts harness the capabilities, infrastructure and expertise of a diversified pharmaceutical service provider with more than 57 years’ building success stories with 200+ multinational clients. Our understanding of the shifting market dynamics allows us to deliver tailored specialist solutions for our clients’ changing needs throughout the product lifecycle, from expanded access programs to strategic regulatory support to commercial execution.
Hosting Partners
BAP Pharma
BAP Pharma is an award-winning, responsive and cost-effective medicines access solutions partner, specialising in providing tailored access solutions to health care professionals and patients. Our experts in Early and Managed Access Programs (EAP/MAP) can assist and support your efforts to bring critical treatments to patients in need, ensuring they get the medicines they need, when they need them, anywhere in the world.
Bionical Emas
Bionical Emas is a global Early Access Programs (EAP) specialist bringing life-changing medicines to patients around the world. Their comprehensive suite of services and capabilities benefit many of the world’s leading pharma and biotech companies.
Bionical Emas provides in-house, highly specialized and EAP centric clinical services, including dedicated Real-World Evidence, Pharmacovigilance and Medical teams to support all program requirements. Their vast experience in oncology and rare disease, and dedicated EAP teams and processes, are essential to providing innovative EAP solutions to pharma and biotech companies globally.
With a truly patient focused approach, Bionical Emas offers a best-in-class EAP service offering ensuring patient, healthcare professional and client needs are met through passionate and tailored program delivery.
Marken
Marken is the clinical and advanced therapy subsidiary of UPS Healthcare. With Marken, Polar Speed and BOMI Group included, the UPS Healthcare network consists of 200+locations worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 49 locations worldwide, while maintaining the leading position for cell and gene therapy services, direct-to-patient and home healthcare services, biological sample shipments and biological kit production. Marken’s dedicated 2,600+ staff members manage 200,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 16,000+ home healthcare visits. Additional services such as ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry. Delivering What Matters From Clinical to Commercial.
Event Partner
MedaSystems
MedaSystems' software is trusted by pharmaceutical companies across the United States and Europe to enhance patient outcomes and streamline the management of drugs under various pre-approval access pathways. Numerous major academic institutions actively use it, and our research and development efforts are grounded in thousands of hours spent collaborating with experts in global pre-approval access.
Life Science Companies use MedaSystems to:
- Easily collaborate with healthcare providers
- Make approval decisions faster
- Reduce frustrating repetitive manual steps
- Capture real-world data
- Comply with regulations
Exhibition Partner
Almac Clinical Services
Almac Clinical Services dedicated Unlicensed Medicine Services group currently manage over 200+ active Managed Access programs, delivering critical medication to patients across 80 countries worldwide. From forecasting and production through to storage and distribution, Almac provides the global reach, expert people, validated processes, and cutting edge technology to empower sponsors to maintain ethical, compliant, and cost- effective access to unlicensed treatments.